Medtronic Minimed, Inc.

This study checks if a new insulin pump (NMX8) and a continuous glucose monitor are safe for people with type 1 or type 2 diabetes. About 400 participants aged 7 to 85 will use the system for up to 90 days while tracking meals and exercise. The goal is to see how well the system …

This study tests a new implantable insulin pump for adults with type 1 diabetes whose blood sugar is hard to control with standard insulin shots or external pumps. The pump is placed inside the body and delivers insulin directly. The goal is to see if it works accurately and help…

This study checks if a new adhesive for a future patch pump stays on the skin for 7 days. About 175 adults with insulin-requiring diabetes will wear the device on different body spots. The goal is to see how often the pump sticks successfully by day 5 and day 7.